Added to YB: 2026-02-11
Pitch date: 2026-02-09
HIMS [neutral]
Hims & Hers Health, Inc.
+8.72%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.7B
Pitch Price
$18.70
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.69
P/E
32.11
EV/Sales
1.83
Sector
Health Care Providers and Services
Category
special_situation
The Hassle Around $HIMS Explained + My Opinion
HIMS (hold): FDA shortage end forced exit from profitable compounded semaglutide injectables. Attempted pivot to $49/mo oral version faced legal challenges from Novo & FDA over missing SNAC absorption tech, forcing another exit. Stock -20% single day. Positive: labs launch, Canada/UK expansion, cancer testing. Holding pending clarity on GLP-1 pivot strategy.
Read full article (5 min)